Adewole S. Adamson
Podcast Host at JAMA Dermatology Author Interviews (Podcast)
Web Editor at JAMA (The Journal of the American Medical Association)
Dermatologist | Health Services Researcher | Alum: @Morehouse @HarvardMed @MIT_HST @Kennedy_School | A naive EBM aficionado| Cancer researcher | Melanoma expert
Articles
-
Mar 9, 2025 |
dermatologytimes.com | Emma Andrus |Adewole S. Adamson
Adewole (Ade) Adamson, MD, MPP, FAAD, assistant professor in the Department of Dermatology at Dell Medical School, University of Texas at Austin, presented a session titled, "The 2025 Debates: Controversies in Dermatology," at the 2025 American Academy of Dermatology (AAD) Annual Meeting.
-
Mar 8, 2025 |
dermatologytimes.com | Emma Andrus |Adewole S. Adamson
Adewole (Ade) Adamson, MD, MPP, FAAD, assistant professor in the Department of Dermatology at Dell Medical School, University of Texas at Austin, presented a session titled, "Approach to Melanoma Diagnosis" at the 2025 American Academy of Dermatology (AAD) Annual Meeting. The session also tackled the increasingly significant topic of melanoma overdiagnosis, which has garnered heightened attention in recent years.
-
Mar 7, 2025 |
dermatologytimes.com | Emma Andrus |Adewole S. Adamson
Adewole (Ade) Adamson, MD, MPP, FAAD, assistant professor in the Department of Dermatology at Dell Medical School, University of Texas at Austin, is preparing for this week's 2025 American Academy of Dermatology (AAD) Annual Meeting, which will take place from March 7-11 in Orlando, Florida. At the meeting, Adamson will be participating in 2 sessions: "Approach to Melanoma Diagnosis" and "The 2025 Debates: Controversies in Dermatology," both of which will take place on Friday, March 7.
-
Aug 28, 2024 |
jamanetwork.com | Ayisha N. Mahama |Courtney Haller |Adewole S. Adamson |LIVESTRONG Cancer Institutes
Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma—What’s in a Name?—Reply Experience and Fear of Cancer Recurrence Among Survivors of Localized Melanoma Ayisha N. Mahama, MD, MPH; Courtney N. Haller, MD; Jocelyn Labrada, BA; Christie I. Idiong, MS; Alex B. Haynes, MD, MPH; Elizabeth A. Jacobs, MD,, MAPP; Joel Tsevat, MD, MPH; Michael P. Pignone, MD, MPH; Adewole S.
-
Aug 21, 2024 |
statnews.com | Adewole S. Adamson |Vishal Patel |H. Gilbert Welch
For years, Black Americans have been more likely to die of cancer than white Americans. There is a widespread belief that cancer screening — tests to detect hidden cancer — can reduce this Black-white disparity. While it is important to be attentive to racial disparities in health and health care, the belief in screening is misguided. More cancer screening primarily serves the interests of the health care system, not those of Black Americans.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 7K
- Tweets
- 17K
- DMs Open
- Yes
RT @pash22: Promises and Pitfalls of 3D Total-Body Photography for Melanoma Early Detection https://t.co/eKRmIR0MJE via @AdeAdamson et al
RT @NEJM: A new article from the @US_FDA compares broad U.S. recommendations on Covid vaccination with those from other countries and annou…
RT @DickieV: Heading now for bloodwork - & PET SCAN - it is a time filled with loads of ANXIETY. Just ask cancer patients - as most of u…
